© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Leukemia and Lymphoma
FDA Roundup: New Indication for Ayvakit, OTC Switch
June 19, 2021
A new indication, a nonprescription switch, a recall, and new guidances round out this week’s FDA news.
FDA Updates: Blood Cancers, Orphan Drug Designations Get Priority
August 02, 2020
In a busy week, FDA approved ground-breaking therapies in hematologic cancers and issued Orphan Drug designations in areas of significant unmet need.
Bringing Value to Cancer Care
July 25, 2019
How a tool is helping execs define and measure value in oncology.
Four Things to Know About Providing CAR T-Cell Treatment
July 14, 2019
Top oncology experts share how they deliver these therapies to patients in need.
How Immuno-Oncology Biomarkers Are Changing Cancer Care
May 01, 2019
With so many new immunotherapy treatments on the horizon, pharmacists need to understand the ins and outs of immuno-oncology biomarkers to best serve their patients.
From MACRA to Burnout: How Oncologists Really Feel
December 15, 2018
New research from Cardinal Health Specialty Solutions has surprising findings about oncologists from meeting MACRA requirements to burnout.
14 Ways to Make Cancer Patients More Comfortable
December 05, 2018
Ways to help lessen the stress that can come with cancer treatments.
How Health Execs Can Expand Access to Oncologists
December 01, 2018
A study from Doximity has shocking statistics about oncologist shortages in the U.S. Here’s how you should react.
The Alternative Cancer Treatments Health Execs Are Talking About
December 01, 2018
A Managed Healthcare Executive’s cancer management survey revealed support for the selected use of complementary and alternative medicine. Where do things stand in what some consider a promising treatment area?
Five Things to Know About Cancer Immunotherapy
November 30, 2018
As immunotherapy breaks through in cancer therapy, here are five things to know about this promising treatment.